Usefulness of beta blockade in contemporary management of patients with stable coronary heart disease

American Journal of Cardiology

Volumn 114, Issue 10, 2014, Pages 1607-1612

  Winchester, David E ^a   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPRANOLOL; TRANDOLAPRIL PLUS VERAPAMIL;

ANGIOPLASTY; ATRIOVENTRICULAR BLOCK; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD CLOT LYSIS; BRADYCARDIA; BRONCHOSPASM; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR STENT; CORONARY ARTERY BYPASS SURGERY; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HISTORY OF MEDICINE; HUMAN; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID OXIDATION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL DYSFUNCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERMOGENESIS; VASOMOTOR DISORDER; WEIGHT GAIN; CORONARY ARTERY DISEASE; DISEASE MANAGEMENT; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CORONARY ARTERY DISEASE; DISEASE MANAGEMENT; HUMANS; TREATMENT OUTCOME;

EID: 84908349878     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.08.026     Document Type: Review

References (50)

1. S. Bangalore, G. Steg, P. Deedwania, K. Crowley, K.A. Eagle, S. Goto, E.M. Ohman, C.P. Cannon, S.C. Smith, U. Zeymer, E.B. Hoffman, F.H. Messerli, and D.L. Bhatt Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease JAMA 308 2012 1340 1349
2. G. Montalescot, U. Sechtem, S. Achenbach, F. Andreotti, C. Arden, A. Budaj, R. Bugiardini, F. Crea, T. Cuisset, C. Di Mario, J.R. Ferreira, B.J. Gersh, A.K. Gitt, J.S. Hulot, N. Marx, L.H. Opie, M. Pfisterer, E. Prescott, F. Ruschitzka, M. Sabate, R. Senior, D.P. Taggart, E.E. van der Wall, C.J. Vrints, J.L. Zamorano, H. Baumgartner, J.J. Bax, H. Bueno, V. Dean, C. Deaton, C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A.W. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M.F. Piepoli, P. Ponikowski, P.A. Sirnes, J.L. Tamargo, M. Tendera, A. Torbicki, W. Wijns, S. Windecker, M. Valgimigli, M.J. Claeys, N. Donner-Banzhoff, H. Frank, C. Funck-Brentano, O. Gaemperli, J.R. Gonzalez-Juanatey, M. Hamilos, S. Husted, S.K. James, K. Kervinen, S.D. Kristensen, A.P. Maggioni, A.R. Pries, F. Romeo, L. Ryden, M.L. Simoons, P.G. Steg, A. Timmis, and A. Yildirir 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J 34 2013 2949 3003
3. S.D. Fihn, J.M. Gardin, J. Abrams, K. Berra, J.C. Blankenship, A.P. Dallas, P.S. Douglas, J.M. Foody, T.C. Gerber, A.L. Hinderliter, S.B. King 3rd, P.D. Kligfield, H.M. Krumholz, R.Y. Kwong, M.J. Lim, J.A. Linderbaum, M.J. Mack, M.A. Munger, R.L. Prager, J.F. Sabik, L.J. Shaw, J.D. Sikkema, C.R. Smith Jr., S.C. Smith Jr., J.A. Spertus, S.V. Williams, and J.L. Anderson 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 126 2012 e354 e471
4. CDC CDC health disparities and inequalities report - United States, 2011 Morbid Mort Week Rep 60 Suppl 2011 1 113
5. R.P. Ahlquist Adrenergic receptors: a personal and practical view Perspect Biol Med 17 1973 119 122
6. S.T. O'Rourke Antianginal actions of beta-adrenoceptor antagonists Am J Pharm Educ 71 2007 95
7. N. Clark-Turner Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris Drugs 38 Suppl 2 1989 55 60
8. P. Blake, S.C. Berry, A. Readman, M. Ratcliffe, and M. Godley A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial Cardiology 79 1991 249 255
9. A.S. Ling, and J.T. Groel Improved physical performance as a therapeutic objective in patients with angina Br J Clin Pharmacol 7 Suppl 2 1979 161S 166S
10. BHAT Investigators A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results JAMA 247 1982 1707 1714
11. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta Blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
12. CDC Achievements in public health, 1900-1999: decline in deaths from heart disease and stroke - United States, 1900-1999 Morbid Mort Week Rep 48 1999 649 656
13. M. Nichols, N. Townsend, P. Scarborough, and M. Rayner Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009 Eur Heart J 34 2013 3017 3027
14. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, T.E. Kottke, W.H. Giles, and S. Capewell Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
15. C.M. Pratt, R.P. McMahon, S. Goldstein, C.J. Pepine, T.C. Andrews, I. Dyrda, W.H. Frishman, N.L. Geller, J.A. Hill, N.A. Morgan, P.H. Stone, G.L. Knatterud, G. Sopko, and C.R. Conti Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study) Am J Cardiol 77 1996 1302 1309
16. C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff, R.G. Marks, P. Kowey, F.H. Messerli, G. Mancia, J.L. Cangiano, D. Garcia-Barreto, M. Keltai, S. Erdine, H.A. Bristol, H.R. Kolb, G.L. Bakris, J.D. Cohen, and W.W. Parmley A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2003 2805 2816
17. G.L. Bakris, E. Gaxiola, F.H. Messerli, G. Mancia, S. Erdine, R. Cooper-DeHoff, and C.J. Pepine Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study Hypertension 44 2004 637 642
18. D.E. Winchester, R.M. Cooper-Dehoff, Y. Gong, E.M. Handberg, and C.J. Pepine Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: new data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST) Clin Cardiol 36 2013 442 447
19. K.L. Park, R.J. Goldberg, F.A. Anderson, J. Lopez-Sendon, G. Montalescot, D. Brieger, K.A. Eagle, A. Wyman, J.M. Gore, and Global Registry of Acute Coronary Events Investigators Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE) Am J Med 127 2014 503 511
20. S. Bangalore, H. Makani, M. Radford, K. Thakur, B. Toklu, S.D. Katz, J.J. DiNicolantonio, P.J. Devereaux, K.P. Alexander, J. Wetterslev, and F.H. Messerli Clinical outcomes with beta-blockers for myocardial infarction a meta-analysis of randomized trials Am J Med 2014 10.1016/j.amjmed.2014.05.032
21. P.R. Kalra, C. Morley, S. Barnes, I. Menown, G. Kassianos, S. Padmanabhan, S. Gupta, and C.C. Lang Discontinuation of beta-blockers in cardiovascular disease: UK primary care cohort study Int J Cardiol 167 2013 2695 2699
22. J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A.P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, P. Lechat, and C. Torp-Pedersen Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
23. P. Deedwania Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating beta-blockers J Clin Hypertens 13 2011 52 59
24. R. Cooper-Dehoff, J.D. Cohen, G.L. Bakris, F.H. Messerli, S. Erdine, A.C. Hewkin, S. Kupfer, and C.J. Pepine Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]) Am J Cardiol 98 2006 890 894
25. O. Vardeny, H. Uno, E. Braunwald, J.L. Rouleau, B. Gersh, A.P. Maggioni, M. Domanski, M.A. Pfeffer, and S.D. Solomon Opposing effects of beta blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease Am J Cardiol 107 2011 1705 1709
26. P. Lee, A.P. Kengne, J.R. Greenfield, R.O. Day, J. Chalmers, and K.K. Ho Metabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic? Int J Obes (Lond) 35 2011 1395 1403
27. D.S. Bell, G.L. Bakris, and J.B. McGill Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients Diabetes Obes Metab 11 2009 234 238
28. A. Head Exercise metabolism and beta-blocker therapy. An update Sports Med 27 1999 81 96
29. D.T. Ko, P.R. Hebert, C.S. Coffey, A. Sedrakyan, J.P. Curtis, and H.M. Krumholz Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction JAMA 288 2002 351 357
30. F.H. Messerli, and E. Grossman Beta-blocker therapy and depression JAMA 288 2002 1845 1846 author reply 1846
31. J.W. Knarr Letter: impotence from propranolol? Ann Intern Med 85 1976 259
32. A. Silvestri, P. Galetta, E. Cerquetani, G. Marazzi, R. Patrizi, M. Fini, and G.M. Rosano Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo Eur Heart J 24 2003 1928 1932
33. L.D. Ried, M.J. Tueth, E. Handberg, S. Kupfer, and C.J. Pepine A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST) Psychosom Med 67 2005 398 406
34. S.A. Salem, and D.G. McDevitt Central effects of beta-adrenoceptor antagonists Clin Pharmacol Ther 33 1983 52 57
35. R.M. Robertson, A.J. Wood, W.K. Vaughn, and D. Robertson Exacerbation of vasotonic angina pectoris by propranolol Circulation 65 1982 281 285
36. A.J. Marshall, C.J. Roberts, and D.W. Barritt Raynaud's phenomenon as side effect of beta-blockers in hypertension Br Med J 1 1976 1498 1499
37. R.N. Fogoros Exacerbation of intermittent claudication by propranolol N Engl J Med 302 1980 1089
38. E.D. Frohlich, R.C. Tarazi, and H.P. Dustan Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy JAMA 208 1969 2471 2472
39. S.C. Paravastu, D.A. Mendonca, and A. da Silva Beta blockers for peripheral arterial disease Eur J Vasc Endovasc Surg 38 2009 66 70
40. K. Radack, and C. Deck Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials Arch Intern Med 151 1991 1769 1776
41. M. Gheorghiade, and S. Goldstein Beta-blockers in the post-myocardial infarction patient Circulation 106 2002 394 398
42. S.S. Gottlieb, R.J. McCarter, and R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
43. S.C. Smith Jr., S.N. Blair, R.O. Bonow, L.M. Brass, M.D. Cerqueira, K. Dracup, V. Fuster, A. Gotto, S.M. Grundy, N.H. Miller, A. Jacobs, D. Jones, R.M. Krauss, L. Mosca, I. Ockene, R.C. Pasternak, T. Pearson, M.A. Pfeffer, R.D. Starke, and K.A. Taubert AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 104 2001 1577 1579
44. S.C. Smith Jr., S.N. Blair, M.H. Criqui, G.F. Fletcher, V. Fuster, B.J. Gersh, A.M. Gotto, K.L. Gould, P. Greenland, S.M. Grundy, M.N. Hill, M.A. Hlatky, N. Houston-Miller, R.M. Krauss, J. LaRosa, I.S. Ockene, S. Oparil, T.A. Pearson, E. Rapaport, and R.D. Starke AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel J Am Coll Cardiol 26 1995 292 294
45. S.C. Smith Jr., E.J. Benjamin, R.O. Bonow, L.T. Braun, M.A. Creager, B.A. Franklin, R.J. Gibbons, S.M. Grundy, L.F. Hiratzka, D.W. Jones, D.M. Lloyd-Jones, M. Minissian, L. Mosca, E.D. Peterson, R.L. Sacco, J. Spertus, J.H. Stein, and K.A. Taubert AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association J Am Coll Cardiol 58 2011 2432 2446
46. D.F. Shu, B.R. Dong, X.F. Lin, T.X. Wu, and G.J. Liu Long-term beta blockers for stable angina: systematic review and meta-analysis Eur J Prev Cardiol 19 2012 330 341
47. P.L. Thompson Should beta-blockers still be routine after myocardial infarction? Curr Opin Cardiol 28 2013 399 404
48. F.H. Messerli, S. Bangalore, S.S. Yao, and J.S. Steinberg Cardioprotection with beta-blockers: myths, facts and Pascal's wager J Intern Med 266 2009 232 241
49. S.C. Smith Jr., J. Allen, S.N. Blair, R.O. Bonow, L.M. Brass, G.C. Fonarow, S.M. Grundy, L. Hiratzka, D. Jones, H.M. Krumholz, L. Mosca, R.C. Pasternak, T. Pearson, M.A. Pfeffer, and K.A. Taubert AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372
50. T.D. Fraker Jr., S.D. Fihn, R.J. Gibbons, J. Abrams, K. Chatterjee, J. Daley, P.C. Deedwania, J.S. Douglas, T.B. Ferguson Jr., J.M. Gardin, R.A. O'Rourke, S.V. Williams, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, J.L. Halperin, S.A. Hunt, H.M. Krumholz, F.G. Kushner, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel, L.G. Tarkington, C.W. Yancy American College of Cardiology American Heart Association American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group 2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina Circulation 116 2007 2762 2772